🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of Intermittent Fasting on Sleep and Quality of Life

RecruitingNAAges 18 Years - 65 YearsAllUniversité Libre de Bruxelles
NCT06959069 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to investigate the impact of intermittent fasting on sleep, quality of life and fatigue among healthy volunteers. The main questions aim to answer: Whether intermittent fasting would allow participants to experience an improvement in their sleep quality, duration and latency? Whether intermittent fasting would ameliorate participants' quality of life and reduce chronic fatigue symptoms? Researchers will compare the two most prevailing fasting windows of intermittent diet including an early morning feeding window (8 a.m.-4 p.m.) and a late feeding window (12 p.m.-8 p.m.) to see if there is a difference among these feeding windows on sleep and quality of life. Participants will: * Be divided into two groups (group A and group B) that will alternate their fasting windows. * Group A will start with intermittent fasting over a feeding period from 12 p.m.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Healthy subjects * Adult subjects - age: between 18 and 65 years old * Subjects with a BMI between 18.5 and 29.9 kg/m\^2 * Male and female subjects Exclusion Criteria: * Subjects \< 18 years old * Subjects with Diabetes Mellitus (type 1 and type 2) * Pregnant and/or breastfeeding and/or postpartum women * Underweight subjects (BMI \< 18.5) * Obese subjects (BMI \> 30) * Subjects with confirmed sleep disorders (requiring CPAP or sleep medication (sleeping pills)) * Subjects with renal failure (GFR \< 30 ml/min/1.73 m\^2) or liver disorder * Subjects with serious cardiovascular, respiratory, neurological, or metabolic medical conditions * Subjects with malignant tumors * Subjects with a serious mental disorder requiring medication (e.g., antidepressants or anxiolytics) * Subjects with eating disorders * Subjects who have undergone major surgery or have been hospitalized due to major medical condition (surgery, stay in intensive care) within the last one year * Subjects who have lost more than 10% of their body weight within the last one year * Subjects actively participating in a weight-loss program * Subjects with alcohol use disorder (maximum 10 standard alcoholic drinks per week, 2 standard alcoholic drinks per day) * Subjects with substance use disorder * Subjects unable to provide informed consent * Subjects who do not participate simultaneously in another clinical trial
💊

What it tests

  • Intermittent Fasting - Late feeding window
  • Intermittent Fasting - Early feeding window
📍

Where

1 site
Libre University, Faculty of Human Motor Sciences, Campus Erasme
Brussels, Belgium
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy